Visceral Leishmaniasis
📧 Sign up to get email alerts when something new happens for Visceral Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia
A completed clinical trial sponsored by Instituto de Salud Carlos III in Ethiopia examined visceral leishmaniasis in the context of malnutri…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh [NA]
A completed clinical trial evaluating the effectiveness of paromomycin administered by intramuscular injection for visceral leishmaniasis in…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis [Phase 4]
Phase 4 clinical trial update evaluating a single-dose liposomal amphotericin B regimen for visceral leishmaniasis, sponsored by Banaras Hin…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Community Trial for Visceral Leishmaniasis (VL) [NA]
A community trial for visceral leishmaniasis conducted by the International Centre for Diarrhoeal Disease Research, Bangladesh has completed…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating a short course combination of miltefosine and liposomal amphoter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar [Phase 3]
A Phase 3 trial evaluating single infusions of amphotericin B lipid formulations for visceral leishmaniasis (Kala-azar) has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Combination Therapy in Indian Visceral Leishmaniasis [Phase 3]
A Phase 3 clinical trial in India evaluating a combination therapy for visceral leishmaniasis has completed. The study was conducted at Bana…
-
CLINICAL_TRIALS trial_result · 2010-02-11Clinical Trial Update: Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis [Phase 3]
Completed Phase 3 clinical trial evaluating different combination regimens for visceral leishmaniasis, focusing on safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2009-11-04Clinical Trial Update: Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar [NA]
A completed clinical trial assessed the efficacy, acceptability, and cost-effectiveness of long-lasting insecticidal nets for preventing vis…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis [Phase 3]
A Phase 3 trial evaluating a single-infusion regimen of liposomal amphotericin B for visceral leishmaniasis in India has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: Combination Chemotherapy for the Treatment of Indian Kala-Azar [Phase 2]
Phase 2 clinical trial update showing completion of a combination chemotherapy regimen for visceral leishmaniasis (Kala-Azar) in India.
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar [Phase 2]
Phase II study evaluating safety and efficacy of short-course amphotericin B emulsion regimens for visceral leishmaniasis (kala-azar) has co…
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: Amphotericin B Treatment in Visceral Leishmaniasis [NA]
A completed clinical trial evaluating Amphotericin B for the treatment of visceral leishmaniasis.
-
CLINICAL_TRIALS trial_result · 2008-09-12Clinical Trial Update: An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis [Phase 3]
A Phase 3 open-label randomized trial evaluating a short course of paromomycin for visceral leishmaniasis has completed.